You searched for "regulation"
Glaukos Launches iStent infinite® in the UK Following MDR Approval
Glaukos has announced the launch of its latest glaucoma treatment, iStent infinite®, in the UK market after securing approval under the European Medical Device Regulation (MDR). This new approval process is rigorous and provides ophthalmologists with reassurance regarding the efficacy...
Nicotine accelerates diabetes induced retinal changes
This study investigated the influence of nicotine in an experimentally induced diabetic rat model. They used non-invasive high-resolution spectral domain optical coherence tomography (SD-OCT) imaging to provide quantitative information on the temporal alterations of retinal structures at the micrometer resolution...
Protecting retinal ganglion cells
Glaucoma is considered to be a heterogeneous group of conditions giving retinal ganglion cells (RGC) damage. Lowering intraocular pressure (IOP) reduces the risk of progressive RGC loss in glaucoma. Regeneration of the optic nerve has been shown to restore some...European optical industry leaders gather in London
Keeping a close eye on new products entering the market, European optical industry leaders, as EUROM 1 Optical Industries, have gathered in Pall Mall, London. They discussed new standards and the collective approach also brought insightful state-of-the-market reports from each...Providing primary eyecare services during a global pandemic: the new normal
It would be fair to say that 2020 hasn’t quite turned out to be the year that anyone predicted. Living with a global pandemic has become our reality and we are having to get used to many aspects of our...Sustainability in eyecare: Intraocular gases and the climate emergency
In 2020 the NHS became the first national health system to commit to delivering ‘net zero’ carbon emissions by 2040. The author investigates how the impact of ophthalmic surgery can be reduced. Medical gases have been used in ophthalmic surgery...
Complement Factor H and Factor H-Like protein are expressed in human RPE cells
The role of inflammation in age-related macular degeneration (AMD) is well documented and the association of AMD with the inflammatory marker C-reactive protein (CRP) and members of the complement system underline the role of complements in AMD. Human complement factor...AOP responds to GOC consultation on contact lens care
The regulator is reviewing the process for verifying contact lens specifications and the definition of patient aftercare.AOP welcomes focus on improved patient outcomes in Pharmacy Supervision Review Group report
Recommendations review legislative framework for the future delivery of pharmacy.An introduction to research governance
Research is the process of acquiring new generalisable knowledge and should be fully integrated into health care work. There is a growing drive to encourage and further develop evidence-based practice in ophthalmology so that staff and patients benefit from improved...Emerging therapies for geographic atrophy: complement inhibitors show potential to slow progression and preserve RPE and photoreceptor integrity
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterised by progressive, irreversible loss of the retinal pigment epithelium (RPE) and photoreceptors and is estimated to account for approximately 10% of AMD-related blindness [1-4]. The Age-Related Eye...
